Skip to main content
. 2022 Oct 31;47(12):729–741. doi: 10.1159/000527713

Fig. 7.

Fig. 7

Potential mechanisms for Smad3 to promote cisplatin-induced acute kidney injury. Cisplatin activates Smad3 phosphorylation and then decreases lncRNA Arid2-IR, thus causing tubular epithelial cell (TEC) growth arrest at the G1 cell cycle. Inhibiting Smad3 (SIS3) reduced Smad3 phosphorylation and then increased lncRNA Arid2-IR by binding to TFRC, improving cell cycle disorders, decreasing cell apoptosis, and increasing cell regeneration.